Skip to navigation
Skip to main content
Menu
Close
Search...
Submit
Prostate Cancer
ED
CKD
Urology
Open Submenu
Urology
Back
Urology News
Conference Coverage
Benign Prostatic Hyperplasia (BPH)
Bladder Cancer
Erectile Dysfunction
Hypogonadism
Kidney Cancer
Kidney Stones
Men’s Health
Overactive Bladder (OAB)
Premature Ejaculation
Prostate Cancer
Reproductive Medicine
Upper Tract Urothelial Carcinoma
Urinary Incontinence
Urinary Tract Infections (UTI)
Nephrology
Open Submenu
Nephrology
Back
Nephrology
Conference Coverage
Acute Kidney Injury
Anemia
Contrast Nephropathy
Cardiovascular Disease (CVD)
Chronic Kidney Disease (CKD)
Diabetes
Diabetic Nephropathy
End-Stage Renal Disease
Hemodialysis
Hyperkalemia
Hyperphosphatemia
Hypertension
Hyperuricemia
Lupus Nephritis
Nutrition
Peritoneal Dialysis
Secondary Hyperparathyroidism
Transplantation
My Practice
Open Submenu
My Practice
Back
Commentary
Drug Information Database
Ethical Issues in Medicine
HIPAA Compliance
Legal Issues in Medicine
Practice Management
Product Guide
Web Exclusives
Open Submenu
Web Exclusives
Back
Expert Perspectives
Cartoons
Clinical Quiz
Drugs in the Pipeline
Medical Calculators
Medical Charts
Multimedia
Polls
Resources
Open Submenu
Resources
Back
Decision Support in Medicine
Drug Information Database
Jobs
Submit Content
Toggle Search Menu
Headlines
Jobs
Commentary
Poll
Drugs
CME
Login
Register
Submit
Oncology
»
Bladder, kidney, and other urologic cancers
Bladder, kidney, and other urologic cancers
Drug Name
AFINITOR
AVASTIN
BALVERSA
BAVENCIO
CABOMETYX
Cisplatin
COSMEGEN
DEPO-PROVERA
Doxorubicin HCl
Doxorubicin HCl Solution
IMFINZI
INLYTA
KEYTRUDA
LENVIMA
MVASI
NEXAVAR
OPDIVO
PADCEV
PROLEUKIN
SUTENT
TECENTRIQ
TEPADINA
Thiotepa
TICE BCG
TORISEL
VALSTAR
Vincristine Sulfate PFS
VOTRIENT
YERVOY
ZIRABEV
Popular
Emailed
Recent
Loading...
Loading...
Loading...
Close more info about ZIRABEV
Loading...
Close more info about ZIRABEV
Loading...
